|
[1]
|
Zheng, Y., Ley, S.H. and Hu, F.B. (2018) Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. Nature Reviews Endocrinology, 14, 88-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Madonna, R., Pieragostino, D., Balistreri, C.R., et al. (2018) Diabetic Macroangiopathy: Pathogenetic Insights and Novel Therapeu-tic Approaches with Focus on High Glucose-Mediated Vascular Damage. Vascular Pharmacology, 107, 27-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wolf, D. and Ley, K. (2019) Immunity and Inflammation in Ather-osclerosis. Circulation Research, 124, 315-327. [Google Scholar] [CrossRef]
|
|
[4]
|
Katakami, N. (2018) Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus. Journal of Atherosclerosis and Thrombosis, 25, 27-39. [Google Scholar] [CrossRef]
|
|
[5]
|
Scioli, M.G., Cervelli, V., Arcuri, G., et al. (2014) High Insulin-Induced Down-Regulation of Erk-1/IGF-1R/FGFR-1 Signaling Is Required for Oxidative Stress-Mediated Apoptosis of Adi-pose-Derived Stem Cells. Journal of Cellular Physiology, 229, 2077-2087. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Yuan, T., Yang, T., Chen, H., et al. (2019) New Insights into Oxidative Stress and Inflammation during Diabetes Mellitus-Accelerated Atherosclerosis. Redox Biology, 20, 247-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Akbari, M. and Hassan, Z.V. (2018) IL-6 Signalling Pathways and the Development of Type 2 Diabetes. Inflammopharmacology, 26, 685-698. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Cui, R., Sun, S.Q., Zhong, N., et al. (2020) The Relationship be-tween Atherosclerosis and Bone Mineral Density in Patients with type 2 Diabetes Depends on Vascular Calcifications and Sex. Osteoporosis International, 31, 1135-1143. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Luc, K., Schramm-Luc, A., Guzik, T.J., et al. (2019) Oxidative Stress and Inflammatory Markers in Prediabetes and Diabetes. Journal of Physiology and Pharmacology, 70, 809-824.
|
|
[10]
|
Li, Y., Zhao, Y., Tan, X., et al. (2020) Isoorientin Inhibits Inflammation in Macrophages and Endotoxe-mia Mice by Regulating Glycogen Synthase Kinase 3β. Mediators of Inflammation, 2020, Article ID: 8704146. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Slim, C., Zaouali, M.A., Nassrallah, H., et al. (2020) Protective Poten-tial Effects of Fucoidan in Hepatic Cold Ischemia-Rerfusion Injury in Rats. International Journal of Biological Macro-molecules, 155, 498-507. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ayissi Owona, B., Angie Abia, W. and Fewou Moundipa, P. (2020) Natural Compounds Flavonoids as Modulators of Inflammasomes in Chronic Diseases. International Im-munopharmacology, 84, Article ID: 106498. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
万思琦, 刘立亚, 刘梦思, 等. 荭草苷的药理作用机制研究[J]. 医学研究杂志, 2018, 47(6): 183-186.
|
|
[14]
|
Laddha, A.P. and Kulkarni, Y.A. (2019) Tannins and Vascular Com-plications of Diabetes: An Update. Phytomedicine, 56, 229-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cornelius, V.A., Yacoub, A., Kelaini, S. and Margariti, A. (2021) Diabetic Endotheliopathy: RNA-Binding Proteins as New Therapeutic Targets. The International Journal of Bio-chemistry & Cell Biology, 131, Article ID: 105907. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Poznyak, A., Grechko, A.V., Poggio, P., et al. (2020) The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. International Journal of Molecular Sciences, 21, Article No. 1835. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Yu, Z.W., Zhang, J., Li, X., et al. (2020) A New Research Hot Spot: The Role of NLRP3 Inflammasome Activation, a Key Step in Pyroptosis, in Diabetes and Diabetic Complications. Life Sciences, 240, Article ID: 117138. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ding, S., Xu, S., Ma, Y., et al. (2019) Modulatory echanisms of the NLRP3 Inflammasomes in Diabetes. Biomolecules, 9, Article No. 850. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Shi, Y. and Vanhoutte, P.M. (2017) Macro- and Microvascular Endo-thelial Dysfunction in Diabetes. Journal of Diabetes, 9, 434-449. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Rhee, S.Y. and Kim, Y.S. (2018) The Role of Advanced Glycation end Products in Diabetic Vascular Complications. Diabetes & Metabolism Journal, 42, 188-195. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Zeng, C., Li, Y., Ma, J., et al. (2019) Clinical /Translational Aspects of Advanced Glycation End-Products. Trends in Endocrinology and Metabolism, 30, 959-973. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wu, N., Shen, H., Liu, H., et al. (2016) Acute Blood Glucose Fluc-tuation Enhances Rat Aorta Endothelial Cell Apoptosis, Oxidative Stress and Proinflammatory Cytokine Expression in Vivo. Cardiovascular Diabetology, 15, Article No. 109. [Google Scholar] [CrossRef] [PubMed]
|